COMMUNIQUÉS West-GlobeNewswire

Nyxoah Receives $15 Million from the European Investment Bank
17/06/2026
Nyxoah Receives $15 Million from the European Investment Bank Non-dilutive debt funding complements the Company’s June equity raise, bringing total capital raised to $110 million Mont-Saint-Guibert, Belgium – June 17, [...]
Publication relating to transparency notifications
17/06/2026
REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), June 17, 2026 , 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Law of May 2, 2007 on the [...]
Publication relative à des notifications de transparence
17/06/2026
INFORMATION RÉGLEMENTÉE Publication relative à des notifications de transparence Mont-Saint-Guibert (Belgique), le 17 juin 2026 , 22:30h CET / 17:30h ET – Conformément à l'article 14 de la loi du 2 mai 2007 relative à [...]
Legend Biotech Corporation Announces Proposed Public Offering
17/06/2026
BRIDGEWATER, N.J., June 17, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (“Legend Biotech” or the “Company”), a global leader in cell therapy, today announced that it has commenced an underwritten [...]
Certara Announces CFO Transition
17/06/2026
Reaffirms 2026 Guidance RADNOR, Pa., June 17, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, announces that John Gallagher, Chief Financial Officer, has [...]
Satellos Bioscience Announces Results of Annual Meeting of Shareholders
17/06/2026
TORONTO, June 17, 2026 (GLOBE NEWSWIRE) -- Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL) (“ Satellos ” or the “ Company ”), a clinical-stage biotechnology company developing life-improving medicines to treat [...]
Lexeo Therapeutics Announces Publication in JAMA Cardiology of Phase I/II Data for LX2006 in Friedreich Ataxia
17/06/2026
Published findings in JAMA Cardiology demonstrate LX2006 generally well tolerated, with early signs of efficacy in Phase I/II studies SUNRISE-FA 2 pivotal study for LX2006 on track to initiate in Q2 2026 with topline [...]
Nyxoah Reçoit 15 Millions de Dollars de la Banque Européenne d’Investissement
17/06/2026
Nyxoah Reçoit 15 Millions de Dollars de la Banque Européenne d’Investissement Ce financement par dette non dilutif complète l’augmentation de capital de la Société réalisée en juin, portant le montant total des fonds [...]
Postponement and Re-scheduling of Annual General Meeting
17/06/2026
June 17, 2026 Biodexa Pharmaceuticals PLC Postponement and Re-scheduling of Annual General Meeting Biodexa Pharmaceuticals PLC (Nasdaq: BDRX) (“Biodexa” or “Company”), a clinical stage biopharmaceutical company [...]
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17/06/2026
SOUTH SAN FRANCISCO, Calif., June 17, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on June 15, 2026 it granted stock options to purchase an aggregate of 24,784 shares of common [...]
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17/06/2026
WALTHAM, Mass., June 17, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and [...]
Cosmos Health Enters the $163 Billion Global Skincare Market; Sales Already Underway in the United States
17/06/2026
CHICAGO, June 17, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced its entry into the global [...]
Premier Health of America Provides Update on Management Cease Trade Order
17/06/2026
MONTREAL, June 17, 2026 (GLOBE NEWSWIRE) -- PREMIER HEALTH OF AMERICA INC. (TSX-V: PHA) (“Premier Health” , or the “Company” ) is providing this bi-weekly default status report in accordance with National Policy 12-203 [...]
RESTEM to Present at BIO International Convention
17/06/2026
MIAMI, June 17, 2026 (GLOBE NEWSWIRE) -- RESTEM – a clinical-stage biotechnology company that develops off-the-shelf, next-generation cell therapies designed to modulate the immune system, today announced that CEO, [...]
Compte-rendu de l’assemblée générale de TME Pharma
17/06/2026
Compte-rendu de l’assemblée générale de TME Pharma Berlin, Allemagne, le 17 juin 2026, 18 h 30 CET – TME Pharma N.V. (Euronext Growth Paris : ALTME), une société de biotechnologie en phase clinique spécialisée dans le [...]
Minutes of the TME Pharma Annual General Meeting
17/06/2026
Minutes of the TME Pharma Annual General Meeting Berlin, Germany, June 17, 2026, 6:30 p.m. CET – TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company specializing in the development of [...]
Applied Biologics Announces Completion of Planned Enrollment Activities in the CAMPX Randomized Controlled Trial Evaluating XWRAP®
17/06/2026
SCOTTSDALE, Ariz., June 17, 2026 (GLOBE NEWSWIRE) -- Applied Biologics, a biopharmaceutical company advancing novel biologic therapies for serious diseases with significant unmet medical needs, today announced the [...]
AB Science patent for masitinib in the treatment of metastatic castrate resistant prostate cancer formally granted in the United States with a protection until 2042
17/06/2026
PRESS RELEASE AB SCIENCE PATENT FOR MASITINIB IN THE TREATMENT OF METASTATIC CASTRATE RESISTANT PROSTATE CANCER FORMALLY GRANTED IN THE UNITED STATES WITH A PROTECTION UNTIL 2042 THIS POSITIVE DECISION FROM THE USA [...]
Eurobio Scientific: ERRATUM : MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025
17/06/2026
ERRATUM : MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025 Paris, le 17 juin 2026 Eurobio Scientific (FR0013240934, ALERS, éligible PEA-PME), groupe français leader dans le diagnostic médical in vitro pour la [...]

Pages